CIK 0001160308
- Non-accelerated filer
- Smaller reporting company
Savara Inc
Sign in to watch- Ticker
- SVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 841318182
- Phone
- +51 285113796
- Business address
- 6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
- Former names
- Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 72 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-06-11 | Shuster Lewis Director | Grant or award · Stock Option (Right to Buy) | +82,963 | 82,963 | ||
| 2014-06-19 | Shuster Lewis Director | Grant or award · Stock Option (Right to Buy) | +46,609 | 46,609 | ||
| 2013-06-19 | Shuster Lewis Director | Grant or award · Stock Option (Right to Buy) | +62,451 | 62,451 | ||
| 2012-07-28 | Shuster Lewis Director | Grant or award · Stock Option (Right to Buy) | +27,310 | 27,310 | ||
| 2011-06-15 | Shuster Lewis Director | Grant or award · Stock Option (Right to Buy) | +10,480 | 10,480 | ||
| 2011-06-15 | Shuster Lewis Director | Grant or award · Stock Option (Right to Buy) | +10,480 | 10,480 | ||
| 2011-06-15 | Shuster Lewis Director | Grant or award · Stock Option (Right to Buy) | +1,746 | 1,746 |
Page 1 of 1 · 7 trades